Table 4 HPLC separation of the diastereomers (- and -) of
4.73 (1H, m), 5.10 (2H, AB q, J 6.2), 5.21 (1H, br d, J 8), 6.80–
7.39 (4H, m), 7.35 (5H, apparent s).
a
Z-Phe(X)-Leu-NH2
c
c
X
Mobile phaseb
kЈ
kЈ
αd
L-L
D-L
Z-DL-Phe(4F)-OCH2CF3. 91% yield; mp 79–81 ЊC (Found:
C, 57.32; H, 4.37; N, 3.30%); νmax/cmϪ1 3328, 1761, 1687;
δH 3.03–3.20 (2H, d of AB q, J 14.1 and 6.6), 4.37–4.62 (2H, m),
4.75 (1H, m), 5.13 (2H, AB q, J 14.1), 5.19 (1H, br d, J 8),
6.97–7.40 (9H, m).
2F
3F
4F
2Cl
3Cl
4Cl
2Br
3Br
4Br
A
A
A
B
B
B
B
B
B
16.5
18.8
18.8
12.9
15.0
16.3
14.1
17.9
19.5
20.1
22.4
21.5
16.2
18.1
18.3
17.9
21.7
21.5
1.22
1.19
1.14
1.26
1.21
1.12
1.27
1.21
1.10
Z-DL-Phe(2Cl)-OCH2CF3. 91% yield; mp 79–80 ЊC (Found:
C, 55.03; H, 4.09; N, 3.62. C19H17ClF3NO4 requires C, 54.88; H,
4.12; N, 3.37%); νmax/cmϪ1 3352, 1766, 1696; δH 3.15–3.38 (2H,
d of AB q, J 14.1 and 6.3), 4.49 (2H, q, J 8.4), 4.79 (1H, m), 5.07
(2H, AB q, J 12.9), 5.26 (1H, br d, J 8), 7.16–7.39 (9H, m).
a HPLC conditions: see the Experimental section. b A, 55% aq. MeOH
containing H3PO4 (0.01 M); B, 60% aq. MeOH containing H3PO4
(0.01 M). c Capacity factor: kЈ = (tR Ϫ t0)/t0, where t0 = 1.50 min. d Sep-
Z-DL-Phe(3Cl)-OCH2CF3. 86% yield; mp 66–67 ЊC (Found:
C, 54.69; H, 4.36; N, 3.09%); νmax/cmϪ1 3321, 1766, 1689; δH
(DMSO-d6) 2.92 (1H, dd-like, J 13.8 and 5.4), 3.07 (1H, dd-like,
J 13.8 and 5.1), 4.41 (1H, m), 4.78 (2H, q, J 9.0), 4.99 (2H, AB
q, J 12.6), 7.21–7.37 (9H, m), 7.99 (1H, d, J 7.8).
c
aration factor: α = kЈD-L/kЈ
.
L-L
was added EDCؒHCl (190 mg, 1.0 mmol) under ice-cooling.
After stirring at this temperature for 2 h and then at ambient
temperature overnight, the reaction mixture was diluted with
EtOAc, washed successively with 1 M HCl, water, 1 M aq.
NaHCO3 and brine, and dried over Na2SO4. Evaporation of the
solvent in vacuo afforded crystals, which were recrystallised
from aq. MeOH (370 mg, 90%); mp 192.5–193 ЊC; [α]D25 Ϫ18.3
(c 1.0, DMF), Ϫ21.7 (c 1.0, MeOH) {lit.,18 mp 195–196 ЊC;
[α]D25 Ϫ19.7 (c 1, DMF)}; δH (DMSO-d6) 0.83 (3H, d, J 6.3),
0.87 (3H, d, J 6.6), 1.45 (2H, apparent t, J 7), 1.48–1.66
(1H, m), 2.72 (1H, dd, J 13.8 and 11.1), 3.00 (1H, dd, J 13.8
and 3.9), 4.16–4.33 (2H, m), 4.93 (2H, AB q, J 13.2), 6.99
(1H, s), 7.11–7.35 (11H, m), 7.51 (1H, d, J 8.4), 7.97 (1H, d,
J 8.4).
Z-DL-Phe(4Cl)-OCH2CF3. 85% yield; mp 95–101 ЊC (Found:
C, 55.16; H, 4.27; N, 3.39%); νmax/cmϪ1 3343, 1766, 1697;
δH 3.02–3.20 (2H, d of AB q, J 14.1 and 6.0), 4.37–4.63 (2H, m),
4.74 (1H, m), 5.09 (2H, AB q, J 12.3), 5.16 (1H, br d, J 8), 7.02–
7.40 (9H, m).
Z-DL-Phe(2Br)-OCH2CF3. 95% yield; mp 83.5–84 ЊC
(Found: C, 49.50; H, 4.01; N, 3.27. C19H17BrF3NO4 requires C,
49.58; H, 3.72; N, 3.04%); νmax/cmϪ1 3320, 1770, 1697; δH 3.14–
3.41 (2H, m), 4.45–4.55 (2H, m), 4.80 (1H, m), 5.06 (2H, s), 5.27
(1H, br d, J 9), 7.09–7.57 (9H, m).
The mixtures of diastereomers (- and -) of Z-Phe(X)-
Leu-NHPh or Z-Phe(X)-Leu-NH2 were prepared through the
coupling of Z--Phe(X) with -Leu-NHPh or -Leu-NH2 (in
the form of the hydrochloride with an equimolar amount of
TEA) by the EDC–HOBT method in DMF in the same manner
as above and purified by recrystallisation from aq. MeOH.
Each sample thus prepared showed only two peaks, corre-
sponding to both the diastereomers on reversed-phase HPLC.
The faster eluting diastereomer proved to be - by comparison
with authentic samples prepared through the coupling of a very
small amount of Z--Phe(X) (X = 2F, 3F, 4F, 4Cl and 4Br),
which was obtained by enzymic resolution,5,6 with -Leu-NHPh
or -Leu-NH2 salt by the EDC–HOBT method.
Z-DL-Phe(3Br)-OCH2CF3. 88% yield; mp 76–77 ЊC (Found:
C, 49.81; H, 3.67; N, 3.24%); νmax/cmϪ1 3319, 1766, 1689;
δH (DMSO-d6) 2.90 (1H, dd-like, J 12.0 and 10.5), 3.07 (1H,
dd-like, J 12.0 and 4.8), 4.41 (1H, m), 4.77 (2H, q, J 9.0), 4.98
(2H, AB q, J 12.3), 7.20–7.50 (9H, m), 7.98 (1H, d, J 7.8).
Z-DL-Phe(4Br)-OCH2CF3. 85% yield; mp 111–113 ЊC
(Found: C, 49.44; H, 3.59; N, 3.25%); νmax/cmϪ1 3322, 1761,
1687; δH 3.00–3.19 (2H, d of AB q, J 14.1 and 6.3), 4.37–4.63
(2H, m), 4.74 (1H, m), 5.09 (2H, AB q, J 12.3), 5.16 (1H, br d,
J 8), 6.97–7.43 (9H, m).
Preparation of L-Leu-NHPhؒHCl
Preparation of immobilised ꢀ-chymotrypsin
Boc--Leuؒ1/2H2O (2.4 g, 10 mmol), aniline (1.4 g, 15 mmol),
EDTA (60 mg) and -Cys (200 mg) were dissolved in a mixture
of pH 4.8 acetate buffer (140 ml) and DMF (60 ml). After the
pH had been adjusted to 4.8, papain (400 mg) was added and
the mixture was stirred at 38 ЊC for 4 days. The precipitate
was filtered off, washed with the buffer, and dried in a vacuum
desiccator over P4O10. Materials insoluble in EtOAc were fil-
tered off and the filtrate was concentrated to give white crystals
(2.6 g; mp 136–143 ЊC), which were recrystallised from EtOAc–
petroleum spirit to give Boc--Leu-NHPh (1.7 g, 56%); mp 148–
150 ЊC; [α]D25 Ϫ34.8 (c 1.0, MeOH) (Found: C, 70.12; H, 9.28; N,
9.63. C17H26N2O2 requires C, 70.31; H, 9.02; N, 9.65%). Boc--
Leu-NHPh (1.5 g, 5 mmol) thus obtained was stirred in 3.7 M
HCl in 1,4-dioxane (15 ml) for 1.5 h. Evaporation of the solvent
in vacuo afforded white crystals, which were recrystallised from
propan-2-ol–diisopropyl ether to give -Leu-NHPhؒHCl (0.9 g,
74%); mp 218–222 ЊC.
α-Chymotrypsin (32 mg) was dissolved in 4 ml of 0.05 M Tris
buffer (pH 7.8) and mixed with Celite No. 535 (Johns-Mansville
Co., Denver, CO; 1 g), and the mixture was lyophilised using an
Eyela (Japan) freeze-dryer FDU-830 for 20 h.
HPLC analyses
The liquid chromatograph employed was a GL Sciences (Japan)
PU-610 instrument, equipped with a Rheodyne 8125 sample
injector and a GL Sciences UV-620 variable-wavelength UV
monitor. A Shimadzu (Japan) C-R6A data processor was
used for data acquisition and processing. The amounts of the
donor ester, peptide and hydrolysis product of the donor
ester were determined by HPLC analysis on an ODS column
under the following conditions: column, Inertsil ODS 3 (5 µm;
1.5 mm id × 150 mm, GL Sciences); mobile phase, 55–60%
aq. MeOH containing H3PO4 (0.01 M); flow rate, 0.1 ml
minϪ1; column temperature, 40 ЊC; detection, UV at 254 nm.
The diastereomers (- and -) of the resulting peptides were
also separated well on the same column by decreasing the
amount of MeOH in the mobile phase. The separation of the
diastereomers (- and -) of Z-Phe(X)-Leu-NH2 is compiled
in Table 4.
Preparation of authentic dipeptides
An authentic sample of Z--Phe--Leu-NH2 was prepared as
follows. To a stirred solution of Z--Phe (300 mg, 1.0 mmol),
-Leu-NH2ؒHCl (130 mg, 1.0 mmol), triethylamine (TEA) (100
mg, 1.0 mmol) and HOBT (135 mg, 1.0 mmol) in DMF (10 ml)
J. Chem. Soc., Perkin Trans. 1, 2001, 82–86
85